Metropolitan Digital

Men's Weekly


.

A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as Russia is

  • Written by Abram L. Wagner, Research Assistant Professor of Epidemiology, University of Michigan
A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as Russia isOn Aug. 11, Russian President Vladimir Putin announced that a coronavirus vaccine developed in the country has been registered for use.Russian Health Ministry/Handout/Anadolu Agency via Getty Images

Russia’s announcement that a fast-tracked COVID-19 vaccine is registered there, with plans for quick distribution in the general population this...

Read more: A COVID-19 vaccine needs the public's trust – and it's risky to cut corners on clinical trials, as...

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more